Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol

BJOG: An International Journal of Obstetrics & Gynaecology

Volumn 98, Issue 5, 1991, Pages 453-459

  HARPER, ANN ^a   MURNAGHAN, G A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE; LABETALOL;

ADULT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MATERNAL HYPERTENSION; PRIORITY JOURNAL; UMBILICAL ARTERY;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FEMALE; HEART RATE; HEART RATE, FETAL; HEMODYNAMICS; HUMAN; HYDRALAZINE; HYPERTENSION; INFUSIONS, INTRAVENOUS; LABETALOL; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULSATILE FLOW; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; UMBILICAL ARTERIES;

EID: 0025910871     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1991.tb10339.x     Document Type: Article

References (36)

1. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy
2. Alpha and beta adrenergic receptor activity in fetal sheep
3. How obstetricians manage hypertension in pregnancy
4. The control of hypertension in pregnancy
5. Cardiovascular responses to hypoxcmia and acidemia in fetal lambs
6. The effect of beta‐adrencrgic stimulation on fetal cardiovascular function during hypoxemia
7. Maternal and fetal cardiovascular indices during fetal hypoxia due to cord compression in chronically cannulated sheep. I. Responses to timolol
8. The pharmacology of isolated sheep umbilical cord blood vessels
9. Umbilical artery blood flow characteristies in normal and growth‐retarded fetuses
10. Intravenous labetalol and intravenous dihydralazinc in severe hypertension in pregnancy
11. Ultrasonic angiology
12. Severe adverse effects of maternal labetalol in a premature infant
13. Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids
14. Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in precclampsia
15. Effects of hydralazine on uteroplacental and fetal circulations
16. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol
17. Transplacental passage and breast milk concentrations of hydralazine
18. Increased heart rate response to parasympathetic and beta adrenergic blockade in growth‐retarded fetal lambs
19. Acute effect of an anti‐hypertensive drug, labetalol, on utero‐placental blood flow
20. Acute effect of dihydralazinc on uteroplacental blood flow in hypertension during pregnancy
21. Uteroplacental blood flow in pregnancy‐induced hypertension
22. A comparative trial of labctalol and hydralazine in the acute management of severe hypertension complicating pregnancy
23. Use of labetalol in the treatment of severe hypertension during pregnancy
24. Characterization of human placental adrenoccptors
25. Effect of propranolol infusion on the umbilical and uterine circulations of pregnant sheep
26. Effect of alpha‐adrenergic agonist and antagonist infusion on the umbilical and uterine circulations of pregnant sheep
27. Fetal haemodynamics before and after treatment of maternal hypertension in pregnancy
28. Pharmacological basis for antihypertensive effects of intravenous labetalol
29. Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes
30. Fetal distress after hydralazine therapy for severe pregnancy‐induced hypertension
31. Effect of dihydralazine on the fetus in the treatment of maternal hypertension
32. Physiological control of the fetal cardiovascular system
33. Labetalol in pregnancy‐induced hypertension: fetal and maternal effects
34. Treatment of acute pregnancy‐related hypertension: labctalol and hydralazine compared
35. Doppler ultrasound assessment of cerebral blood flow in the human fetus
36. Side effects of labetalol in newborn infants